Ionic Ventures, LLC 13D and 13G filings for Vivos Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 4:05 pm Sale | 2024-09-30 | 13G | Vivos Therapeutics, Inc. VVOS | Ionic Ventures, LLC | 83,000 1.800% | -329,064 (-79.86%) | Filing |
| 2024-09-24 2:59 pm Purchase | 2024-09-19 | 13G | Vivos Therapeutics, Inc. VVOS | Ionic Ventures, LLC | 412,064 8.700% | 412,064 (New Position) | Filing |